EUVIMEDEUVIMED entdecken
Open Access

Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus

Binxin Chen, Mingyang Chen, Xiaoyi Pan, Mengru Bai, Dongli Sun, Huidi Jiang, Nengming Lin, Zhiyuan Ma

Drug Metabolism and Disposition · 2025-09 · 53 (9) · 100133

DOI: 10.1016/j.dmd.2025.100133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025-09. Verfasst von Binxin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Zhejiang University, Women's hospital, Hangzhou, China; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of…. Hauptthemen laut MEDLINE: Oxygenases, Diabetes, Gestational, Corticosterone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) significantly increases the risk of various complications during pregnancy and elevates the lifelong susceptibility to metabolic disorders. Previous studies have indicated elevated cortisol levels in women with GDM, and hepatic flavin-containing monooxygenase 3 (FMO3) contributes to diabetes mellitus. However, the specific mechanism by which cortisol affects FMO3 and its roles in GDM remain unclear. This study uncovered a novel signaling axis wherein cortisol/corticosterone elevation during GDM activates the glucocorticoid receptor, thereby inducing hepatic FMO3 upregulation. This molecular cascade culminated in increased hepatic trimethylamine N-oxide production, which exacerbated hyperglycemia through activation of the protein kinase B-forkhead box O1-O1-glucose-6-phosphatase axis. Notably, pharmacological inhibition of FMO3 using 3,3'-Diindolylmethane (a diet-derived bioactive compound) significantly improved glucose tolerance in pregnant mice by suppressing both trimethylamine N-oxide biosynthesis and protein kinase B-forkhead box O1-O1-glucose-6-phosphatase signaling. Our findings elucidated the glucocorticoid-driven regulatory mechanism of hepatic FMO3 in GDM pathogenesis and suggested the potential of the FMO3 inhibitor as a candidate agent for modulating glucose homeostasis in GDM. SIGNIFICANCE STATEMENT: Pregnancy-induced glucocorticoid activates hepatic flavin-containing monooxygenase 3, driving trimethylamine N-oxide production to exacerbate hyperglycemia through the forkhead box O1-O1-glucose-6-phosphatase axis. Our study identifies flavin-containing monooxygenase 3 as a therapeutic target for gestational diabetes mellitus and suggests 3,3'-diindolylmethane as a promising candidate to improve glucose homeostasis in gestational diabetes mellitus management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxygenasesDiabetes, GestationalCorticosteroneLiverReceptors, GlucocorticoidMaleFemaleAnimalsMiceHepatocytesUp-RegulationIndolesHumansPregnancy

Stichwörter der Autor:innen

flavin-containing monooxygenase 3gestational diabetes mellitusglucocorticoids

Substanzen

dimethylaniline monooxygenase (N-oxide forming)OxygenasesReceptors, GlucocorticoidCorticosterone3,3'-diindolylmethaneIndoles

Autor:innen und Institutionen

  • School of Medicine, Zhejiang University, Women's hospital, Hangzhou, China; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou…
  • Laboratory of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou First People's Hospital, Hangzhou, China.
  • School of Medicine, Zhejiang University, Women's hospital, Hangzhou, China.
  • Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou First People's Hospital, Hangzhou, China. Electronic address: lnm1013@zju.ed…

Förderung

  • Zhejiang Province Natural Science Foundation

Zitieren

APA

Chen, B., Chen, M., Pan, X., Bai, M., Sun, D., Jiang, H., Lin, N., & Ma, Z. (2025). Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus. Drug Metabolism and Disposition, 53(9), 100133. https://doi.org/10.1016/j.dmd.2025.100133

Vancouver

Chen B, Chen M, Pan X, Bai M, Sun D, Jiang H, et al. Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus. Drug Metabolism and Disposition. 2025;53(9):100133. doi:10.1016/j.dmd.2025.100133

BibTeX
@article{Chen2025,
  author = {Chen, Binxin and Chen, Mingyang and Pan, Xiaoyi and Bai, Mengru and Sun, Dongli and Jiang, Huidi and Lin, Nengming and Ma, Zhiyuan},
  title = {Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  volume = {53},
  number = {9},
  pages = {100133},
  doi = {10.1016/j.dmd.2025.100133}
}
Kostenlos starten →